• Current position:


Drug

Target

Discovery

Lead

Optimization

IND-

Enabling

Phase I

Phase II

Phase III

Clinical

BB-1701

HER2







BB-1705

EGFR







BB-1709

CD73







BB-1712

B7H3







BB-1710

-







Pre-Clinical

BB-1708

-







BR**

Other preclinical projects